Mexican buy for Pilot

18 December 2019 - 0 Submitted by Andrew Warmington

US speciality chemicals firm Pilot Chemical of Cincinnati has acquired Órgano Síntesis (OSSA), which makes products for the personal care, disinfection, sanitising, cleaning, oil and gas, water treatment and general speciality chemicals industries. Terms were not disclosed.

Pilot said that this expands its business into the Mexican and wider Latin American market, giving growth opportunities for its existing surfactants and antimicrobial businesses. OSSA brings with it technology, a testing and research plant facility, FDA cGMP certification and R&D capabilities. OSSA, which like Pilot was privately owned, will retain its name, with Federico Soto remaining as director general. About 100 employees at the headquarters office in Mexico City and the production site in Toluca will transfer.

Pilot is mainly active in the disinfecting, sanitising and cleaning; metalworking and lubricants; oil field and emulsion polymerization industries. Core technologies involve sulfonation, in which it claims to have North America’s most advanced continous process, plus alkylation, sulfation and the production biocidal quats, tertiary amine derivatives, polymers and organometallic fuel additives.

Feature Article - Addressing the circular economy challenge: A perspective on BFRs

Nov 25, 2020/0

Dr Kevin Bradley, secretary general of the International Bromine Council, takes a look at how brominated flame retardant manufacturers and their associations are addressing the challenges arising from public policy and new business models driving the Circular Economy

Croda, Novasep part of key COVID vaccines

Nov 18, 2020/0

Both Croda International and Novasep are involved in some of the vaccines nearing approval for use in the treatment of COVID-19 it has emerged. This follows on from many other announcements of development agreements involving other fine chemical companies earlier in the year.

Sumitomo Chemical launches SynBio Hub

Nov 18, 2020/0

Shortly after handing over responsibility for biorational-related business to its Valent BioSciences (VBC) subsidiary in Illinois, Sumitomo Chemical has announced plans to establish SynBio Hub within its Biorational Research Centre.

Cambrex expands US API capacity

Nov 18, 2020/0

Small molecule CDMO Cambrex is spending $50 million to expand its mid- and large-scale API manufacturing capacity in Charles City, Iowa. This is the sixth major investment at the site in the past eight years and follows on from a recent, smaller expansion at the site in Karlskroga, Sweden.

Merck KGaA presents sustainability strategy

Nov 18, 2020/0

Alongside its Q3 results, Merck KGaA presented its new sustainability strategy, which it said integrates sustainability “more strongly as an essential component of its corporate strategy”. The bonus pay of board members will be linked to progress in the three specific goals, which are:

CordenPharma further expands peptides

Nov 18, 2020/0

CordenPharma is to expand non-GMP solid-phase peptide synthesis (SPPS) capacity at its centre of excellence for peptide process development and non-GMP manufacturing at Frankfurt, Germany. This should be complete in Q3 2021. The amount invested has not been disclosed.